AI-Based IMT Study
AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment
1 other identifier
observational
80
1 country
1
Brief Summary
Cerebro-vascular and heart diseases have together ranked 4th and 5th place in the 2022 top ten leading causes of death in Hong Kong, taking up more than 15% of the total in an unceasing trend. While conventional carotid ultrasound imaging is nothing short of comprehensive, it is highly operator-dependent and is worsened by the shortage of medical staff in Hong Kong. The seemingly long queue for the expensive health screenings has put the high-risk groups, including but not limited to the elderly, in a vulnerable position as they can hardly perform regular and frequent check-ups. In light of this, our team is determined to research a solution that is conducive to the preventive healthcare of strokes and cardiovascular diseases through one of the newly proposed devices: PyrocksTM Tag Lite. This study aims to investigate an approach for developing a robust deep learning model for analysing ultrasound images and incorporate the model into our established prototype to perform intima-media thickness measurement and risk assessment. Main points that the clinical trial can assist in solving the existing problem: The acquisition procedures are non-invasive, painless, and safe for the participants. Clinical trials \& test data will assist in testing and training our neural network model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
January 6, 2025
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJanuary 10, 2025
January 1, 2025
4 months
January 6, 2025
January 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ultrasound images of their carotid artery
For each human participant, we will collect at least 100 ultrasound images of their carotid artery. In total, there will be approximately 80x100=8000 ultrasound images. From the ultrasound images, we will measure the thickness of the participants' carotid artery wall and assess their cardiovascular risk according to risk charts (if \>1mm: low risk; if \>1mm \& \<2.5mm: intermediate risk; if \>2.5mm: high risk.)
1 day
Secondary Outcomes (1)
AI deep learning model
1 day
Eligibility Criteria
Based on Reference\*, which utilized a sample of 50 subjects to assess the variation in IMT measurements among different observers and to reduce IMT variability through an automated computerized analyzing system, we have chosen a sample size of 80 subjects for our study on the automatic detection of carotid arteries and IMT measurement. This increased sample size is designed to account for potential exclusions due to unacceptable image quality, thereby ensuring that we maintain a sufficient number of high-quality images for analysis. A total of 8000 images shall be obtained. Satisfactory images will be stored into the datasets for the deep learning model. By implementing the convolutional neural network through Tensorflow, the model will learn about the patterns and features of different image data: identify the carotid artery, measure the intima-media thickness and hence classify them into with or without cardiovascular risk according to risk charts.
You may qualify if:
- Adults (over the age of 18 years)(with Elderlies (over the age of 65 years) more preferred)
- Patients with cardiovascular diseases (CVD), including current smokers or diagnosed with diabetes, dyslipidaemia, coronary artery disease, cerebrovascular disease, hypertension, atherosclerotic cardiovascular disease, high blood pressure, high BMI index and those under antihypertensive treatment.
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Shatin, 999077, Hong Kong
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 6, 2025
First Posted
January 10, 2025
Study Start
September 15, 2024
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
January 10, 2025
Record last verified: 2025-01